Purchased an EpiPen in the last 10 years? File a claim now.
Pfizer Inc., Meridian Medical Technologies Inc., and King Pharmaceuticals LLC (collectively known as the “Pfizer defendants”) have agreed to a $345 million settlement in a class-action antitrust lawsuit that claimed they plotted to maintain EpiPen’s monopoly while raising the price of EpiPens from $100 to $600 in less than 10 years.
If you purchased a brand-name or generic EpiPen between August 24, 2011, and November 1, 2020, you may be eligible to file a claim in this lawsuit. A fairness hearing will be held on October 27 to determine whether the proposed settlement is “fair, reasonable, and adequate,” but if you’re one of the 7 million+ consumers eligible to file a claim, you may do so now.
The amount of money individual consumers can receive will be decided closer to the final hearing in October. No documentation is required to file a claim, but you may be asked for additional proof of eligibility, including the following:
- Itemized receipts, canceled checks, or credit card statements
- An EOB (explanation of benefits) from your insurer
- Pharmacy records
- Copies of your EpiPen prescriptions
The deadline to file a claim is November 12, 2021. Claims can be filed online or by submitting this form by mail.